The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-kappa B and MAPK signaling pathway | |
Zhang Yuan[1]; Zhang Lei[2]; Zhang Yi[3]; Xu Jin-Jin[4]; Sun Li-Li[5]; Li Shuang-Zhan[6] | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY |
2016 | |
卷号 | 84页码:1337-1349 |
关键词 | Myocardial fibrosis Liquiritin Inflammation NF-kappa B MAPKs |
ISSN号 | 0753-3322 |
DOI | http://dx.doi.org/10.1016/j.biopha.2016.10.036 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000390438100156 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5199464 |
专题 | 河南大学 |
作者单位 | 1.[1]Department of Cardiology, Huaihe Hospital, Henan University, Kaifeng 475000, China. Electronic address: zhangyuan475000@163.com. 2.[2]Department of Cardiology, Huaihe Hospital, Henan University, Kaifeng 475000, China. 3.[3]Department of Cardiology, The Fifth people's Hospital of Shenzhen City, Shenzhen 518001, China. 4.[4]Department of Cardiology, Huaihe Hospital, Henan University, Kaifeng 475000, China. 5.[5]Department of Cardiology, Huaihe Hospital, Henan University, Kaifeng 475000, China. 6.[6]Department of Cardiology, Huaihe Hospital, Henan University, Kaifeng 475000, China. |
推荐引用方式 GB/T 7714 | Zhang Yuan[1],Zhang Lei[2],Zhang Yi[3],et al. The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-kappa B and MAPK signaling pathway[J]. BIOMEDICINE & PHARMACOTHERAPY,2016,84:1337-1349. |
APA | Zhang Yuan[1],Zhang Lei[2],Zhang Yi[3],Xu Jin-Jin[4],Sun Li-Li[5],&Li Shuang-Zhan[6].(2016).The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-kappa B and MAPK signaling pathway.BIOMEDICINE & PHARMACOTHERAPY,84,1337-1349. |
MLA | Zhang Yuan[1],et al."The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-kappa B and MAPK signaling pathway".BIOMEDICINE & PHARMACOTHERAPY 84(2016):1337-1349. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论